Per Soelberg Sørensen
Professor emeritus, Professor, emeritus
- 2021
- Published
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies
Andersen, J. B., Sharmin, S., Lefort, M., Koch-Henriksen, N., Sellebjerg, F., Sørensen, P. S., Hilt Christensen, C. C., Rasmussen, P. V., Jensen, M. B., Frederiksen, J. L., Bramow, S., Mathiesen, H. K., Schreiber, K. I., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S., Patti, F. & 66 others, , 2021, In: Multiple Sclerosis and Related Disorders. 53, 103012.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges
Ghezzi, A., Amato, M. P., Edan, G., Hartung, H. P., Havrdová, E. K., Kappos, L., Montalban, X., Pozzilli, C., Sørensen, Per Soelberg, Trojano, M., Vermersch, P. & Comi, G., 2021, In: Multiple Sclerosis Journal. 27, 3, p. 479-482 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Transcriptome and Function of Novel Immunosuppressive Autoreactive Invariant Natural Killer T Cells That Are Absent in Progressive Multiple Sclerosis
Carrión, B., Liu, Yawei, Hadi, M., Lundstrom, J., Christensen, J. R., Ammitzbøll, C., Dziegiel, Morten Hanefeld, Sørensen, Per Soelberg, Comabella, M., Montalban, X., Sellebjerg, Finn Thorup & Issazadeh-Navikas, Shohreh, 2021, In: Neurology: Neuroimmunology & Neuroinflammation. 8, 6, 15 p., e1065.Research output: Contribution to journal › Journal article › Research › peer-review
- 2020
- Published
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
Alsharoqi, I. A., Aljumah, M., Bohlega, S., Boz, C., Daif, A., El-koussa, S., Inshasi, J., Kurtuncu, M., Müller, T., Retief, C., Sahraian, M. A., Shaygannejad, V., Slassi, I., Taha, K., Zakaria, M. & Sørensen, Per Soelberg, 1 Jun 2020, In: Neurology and Therapy. 9, 1, p. 55-66 12 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
Sellebjerg, Finn Thorup, Blinkenberg, M. & Sørensen, Per Soelberg, 2020, In: CNS Drugs. 34, 3, p. 269-280 12 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Clinical characteristics and use of disease modifying therapy in the nationwide Danish cohort of paediatric onset multiple sclerosis
Erdal, J. L., Kopp, T. I., Blinkenberg, M., Petersen, T., Sørensen, Per Soelberg & Magyari, M., 2020, In: Multiple Sclerosis and Related Disorders. 37, 101431.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis
Chalmer, T. A., Buron, M., Illes, Z., Papp, V., Theodorsdottir, A., Schäfer, J., Hansen, V., Asgari, N., Skejø, P. B., Jensen, H. B., Sørensen, Per Soelberg & Magyari, M., 2020, In: Journal of neurology, neurosurgery, and psychiatry. 91, 1, p. 67-74Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comorbidity in Multiple Sclerosis
Magyari, M. & Sørensen, Per Soelberg, 2020, In: Frontiers in Neurology. 11, 9 p., 851.Research output: Contribution to journal › Review › Research › peer-review
- Published
Effectiveness of glatiramer acetate in neutralizing antibody-positive patients previously treated with interferon-β
Buron, M. D., Magyari, M., Chalmer, T. A., Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, 2020, In: Multiple Sclerosis and Related Disorders. 39, 101894.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Expert opinion on the use of cladribine tablets in clinical practice
Sørensen, Per Soelberg, Centonze, D., Giovannoni, G., Montalban, X., Selchen, D., Vermersch, P., Wiendl, H., Yamout, B., Salloukh, H. & Rieckmann, P., 2020, In: Therapeutic Advances in Neurological Disorders. 13, 17 p., 1756286420935019.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11025
Most downloads
-
240
downloads
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
184
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
159
downloads
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Research output: Contribution to journal › Journal article › Research › peer-review
Published